Functional mitral regurgitation

Cardiology in Review

Volumn 18, Issue 6, 2010, Pages 285-291

  Schmitto, Jan D ^a   Lee, Lawrence S ^a   Mokashi, Suyog A ^a   Bolman, Ralph M ^a   Cohn, Lawrence H ^a   Chen, Frederick Y ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Chronic heart failure; functional mitral regurgitation; MR; review

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL EVALUATION; CONGESTIVE CARDIOMYOPATHY; DISEASE COURSE; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HUMAN; INCIDENCE; MITRAL ANNULOPLASTY; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW;

DISEASE PROGRESSION; HEART CATHETERIZATION; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MITRAL VALVE; MITRAL VALVE ANNULOPLASTY; MITRAL VALVE INSUFFICIENCY; PROGNOSIS; TIME FACTORS; UNITED STATES;

EID: 77958605968     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/CRD.0b013e3181e8e648     Document Type: Review

References (93)

1. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Eur Heart J. 2003;24:1231-1243.
2. Bonow RO, Carabello BA, Kanu C, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons.
3. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the management of patients with valvular heart disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006;114:e84-e231.
4. ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Am Coll Cardiol. 1998;32:1486-588.
5. Perloff JK, Roberts WC. The mitral apparatus: functional anatomy of mitral regurgitation. Circulation. 1972;46:227-239.
6. Gorman RC, Gorman JH III, Edmunds LH Jr. Ischemic mitral regurgitation. In: Cohn LH, Edmunds LH Jr, eds. Cardiac Surgery in the Adult. New York, NY: McGraw-Hill; 2003:751-769.
7. Iung B. Management of ischemic mitral regurgitation. Heart. 2003;89:459-464.
8. Miller DC. Ischemic mitral regurgitation-repair or replace? J Thorac Car-diovasc Surg. 2000;122:159-162.
9. Michels VV, Moll PP, Miller FA, et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopa-thy. N Engl J Med. 1992;326:77-82.
10. Kandolf R, Hofschneider PH. Viral heart disease. Springer Semin Immuno-pathol. 1989;11:1-13.
11. Why HJ, Meany BT, Richardson PJ, et al. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation. 1994;89:2582-2589.
12. Kuhl U, Noutsias M, Seeberg B, et al. Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart. 1996;75:295-300. (Pubitemid 26094969)
13. Caforio AL, Keeling PJ, Zachara E, et al. Evidence from family studies for autoimmunity in dilated cardiomyopathy. Lancet. 1994;344:773-777.
14. Fairweather D, Frisancho-Kiss S, Njoku DB, et al. Complement receptor 1 and 2 deficiency increases coxsackievirus B3-induced myocarditis, dilated cardiomyopathy, and heart failure by increasing macrophages, IL-1beta, and immune complex deposition in the heart. J Immunol. 2006;176:3516-3524.
15. Schultheiss HP, Bolte HD. Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy. J Mol Cell Cardiol. 1985;17:603-617.
16. Codd MB, Sugrue DD, Gersh BJ, et al. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation. 1989;80:564-572.
17. Bagger JP, Baandrup U, Rasmussen K, et al. Cardiomyopathy in western Denmark. Br Heart J. 1984;52:327-331.
18. Williams DG, Olsen EG. Prevalence of overt dilated cardiomyopathy in two regions of England. Br Heart J. 1985;54:153-155.
19. Cowie MR, Wood DA, Coats AJ, et al. Incidence and aetiology of heart failure; a population-based study. Eur Heart J. 1999;20:421-428.
20. Enriquez-Sarano M, Seward J, Bailey K, et al. Effective regurgitant orifice area: a noninvasive doppler development of an old hemodynamic concept. J Am Coll Cardiol. 1994;23:443-451.
21. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardi-ography: a report from the Task Force on Valvular Regurgitation of the American Society of Echocardiography. J Am Soc Echocardiogr. 2003;16: 777-802.
22. Schwammenthal E, Chen C, Benning F, et al. Dynamics of mitral regurgitant flow and orifice area. Physiologic application of the proximal flow convergence method: clinical data and experimental testing. Circulation. 1994;90: 307-322.
23. Keren G, Bier A, Strom J, Laniado S, et al. Dynamics of mitral regurgitation during nitroglycerin therapy: a Doppler echocardiographic study. Am Heart J. 1986;112:517-525.
24. Lebrun F, Lancellotti P, Pierard LA. Quantitation of functional mitral regurgitation during bicycle exercise in patients with heart failure. J Am Coll Cardiol. 2001;38:1685-1692.
25. Wisenbaugh T, Spann J, Carabello B. Differences in myocardial performance and load between patients with similar amounts of chronic aortic versus chronic mitral regurgitation. J Am Coll Cardiol. 1984;3:916-923.
26. Yiu S, Enriquez-Sarano M, Tribouilloy C, et al. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study. Circulation. 2000;102:1400-1406.
27. Bursi F, Enriquez-Sarano M, Nkomo VT, et al. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation. 2005;111:295-301. (Pubitemid 40165335)
28. Wisenbaugh T, Skudicky D, Sareli P. Prediction of outcome after valve replacement for rheumatic mitral regurgitation in the era of chordal preservation. Circulation. 1994;89:191-197.
29. Matsumura T, Ohtaki E, Tanaka K, et al. Echocardiographic prediction of left ventricular dysfunction after mitral valve repair for mitral regurgitation as an indicator to decide the optimal timing of repair. J Am Coll Cardiol. 2003;42: 458-463.
30. Enriquez-Sarano M, Tajik A, Schaff H, et al. Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications. J Am Coll Cardiol. 1994;24:1536-1543.
31. Crawford M, Souchek J, Oprian C, et al. Determinants of survival and left ventricular performance after mitral valve replacement. Circulation. 1990;81: 1173-1181.
32. Enriquez-Sarano M, Rossi A, Seward J, et al. Determinants of pulmonary hypertension in left ventricular dysfunction. J Am Coll Cardiol. 1997;29:153-159.
33. Pierard LA, Lancellotti P. The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema. N Engl J Med. 2004;351:1627-1634.
34. Grigioni F, Detaint D, Avierinos JF, et al. Contribution of ischemic mitral regurgitation to congestive heart failure after myocardial infarction. J Am Coll Cardiol. 2005;45:260-267.
35. Chen FY, Adams DH, Aranki SF, et al. Mitral valve repair in cardiomyop-athy. Circulation. 1998;98(suppl 19):II124-II127.
36. Lee R, Haluska B, Leung DY, et al. Functional and prognostic implications of left ventricular contractile reserve in patients with asymptomatic severe mitral regurgitation. Heart. 2005;91:1407-1412.
37. Trichon BH, Felker GM, Shaw LK, et al. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol. 2003;91:538-543.
38. Cioffi G, Tarantini L, De Feo S, et al. Functional mitral regurgitation predicts 1-year mortality in elderly patients with systolic chronic heart failure. Eur J Heart Fail. 2005;7:1112-1117.
39. Hickey MS, Smith LR, Muhlbaier LH, et al. Current prognosis of ischemic mitral regurgitation: implications for future management. Circulation. 1988; 78(suppl 1):51-59.
40. Tcheng JE, Jackman JD Jr, Nelson CL, et al. Outcome of patients sustaining acute ischemic mitral regurgitation during myocardial infarction. Ann Intern Med. 1992;117:18-24.
41. Lamas GA, Mitchell GF, Flaker GC, et al. Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and ventricular enlargement investigators. Circulation. 1997;96:827-833.
42. Tribouilloy C, Enriquez-Sarano M, Schaff H, et al. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. Circulation. 1999;99:400-405.
43. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med. 2005;352:875-883. (Pubitemid 40300296)
44. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007;28:230-268.
45. Ngaage DL, Daly RC, Rosales G, et al. Mitral regurgitation surgery in heart failure due to ischemic cardiomyopathy: a 24-year experience. J Heart Valve Dis. 2008;17:251-259.
46. Borger MA, Alam A, Murphy PM, et al. Chronic ischemic mitral regurgitation: repair, replace or rethink? Ann Thorac Surg. 2006;81:1153-1161.
47. Messas E, Pouzet B, Touchot B, et al. Efficacy of chordal cutting to relieve chronic persistent ischemic mitral regurgitation. Circulation. 2003; 108(suppl 2):111-115.
48. Rodriguez F, Langer F, Harrington KB, et al. Importance of mitral valve second-order chordae for left ventricular geometry, wall thickening mechanics, and global systolic function. Circulation. 2004;110(suppl 2):115-122.
49. Yamamoto H, Iguro Y, Sakata R, et al. Effectively treating ischemic mitral regurgitation with chordal cutting in combination with ring annuloplasty and left ventricular reshaping approach. J Thorac Cardiovasc Surg. 2005;130: 589-590.
50. Alfieri O, Maisano F, De Bonis M, et al. The double orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg. 2001;122:674-681. (Pubitemid 35470109)
51. Maisano F, Caldarola A, Blasio A, et al. Midterm results of edge-to-edge mitral valve repair without annuloplasty. J Thorac Cardiovasc Surg. 2003; 126:1987-1997.
52. Bhudia SK, McCarthy MM, Smedira NG, et al. Edge-to-edge (Alifieri) mitral repair. Ann Thorac Surg. 2004;77:1598-1606.
53. Liel-Cohen N, Guerroro JL, Otsuji Y, et al. Design of a new surgical approach for ventricular remodeling to relieve ischemic mitral regurgitation: insights from three-dimensional echocardiography. Circulation. 2000;101:2756-2763.
54. Ramadan R, Al-Attar N, Mohammadi S, et al. Left ventricular infarct plication restores mitral function in chronic ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2005;129:440-442.
55. Menicanti L, Di Donato M, Frigoiola A, et al. Ischemic mitral regurgitation: intraventricular papillary muscle imbrication without mitral ring during left ventricular restoration. J Thorac Cardiovasc Surg. 2002;123:1041-1050.
56. Dor V, Sabatier M, Di Donato M, et al. Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular dysfunction: comparison with a series of large dyskinetic scars. J Thorac Cardiovasc Surg. 1998;116:50-59.
57. Hvass U, Tapia M, Baron F, et al. Papillary muscle sling: a new functional approach to mitral repair inpatients with ischemic left ventricular dysfunction and functional mitral regurgitation. Ann Thorac Surg. 2003;75:809-811.
58. Fundaro P, Pocar M, Moneta A, et al. Posterior mitral valve restoration for ischemic regurgitation. Ann Thorac Surg. 2004;77:729-730.
59. Fann JI, St Goar FG, Komtebedde J, et al. Beating heart catheter-based edge-to-edge mitral valve procedure in a porcine model: efficacy and healing response. Circulation. 2004;110:988-989.
60. Glower DD, Tuttle RH, Shaw LK, et al. Patient survival characteristics after routine mitral valve repair for ischemic mitral regurgitation. J Thorac Car-diovasc Surg. 2005;129:860-868.
61. Wu AH, Aaronson KD, Bolling SF, et al. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol. 2005;45:381-387.
62. Bishay ES, McCarthy PM, Cosgrove DM, et al. Mitral valve surgery in patients with severe left ventricular dysfunction. Eur J Cardiothorac Surg. 2000;17:213-221.
63. Patel JB, Borgeson DD, Barnes ME, et al. Mitral regurgitation in patients with advanced systolic heart failure. J Card Fail. 2004;10:285-291.
64. Cohn LH, Kowalker W, Bhatia S, et al. Comparative morbidity of mitral valve repair versus replacement for mitral regurgitation with and without coronary artery disease [1988 updated 1995]. Ann Thorac Surg. 1995;60:1452-1453.
65. Kouris N, Ikonomidis I, Kontogianni D, et al. Mitral valve repair versus replacement for isolated non-ischemic mitral regurgitation in patients with preoperative left ventricular dysfunction. A long-term follow-up echocardio-graphic study. Eur JEchocardiogr. 2005;6:435-442.
66. Bolling SF, Pagani FD, Deeb GM, et al. Intermediate term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg. 1998;115:381-386.
67. Bolling SF, Deeb GM, Bach DS. Mitral valve reconstruction in elderly, ischemic patients. Chest. 1996;109:35-40.
68. David TE, Uden DE, Strauss H. The importance of the mitral apparatus in left ventricular function after correction of mitral regurgitation. Circulation. 1983;68(suppl 2):76-82.
69. David TE, Armstrong S, Sun Z. Left ventricular function after mitral valve surgery. J Heart Valve Dis. 1995;4(suppl 2):S175-S180.
70. Calafiore AM, Di Mauro M, Gallina S, et al. Mitral valve surgery for chronic ischemic mitral regurgitation. Ann Thorac Surg. 2004;77:1989-1997. (Pubitemid 38686572)
71. Gillinov AM, Wierup PN, Blackstone EH, et al. Is repair preferable for ischemic mitral regurgitation? J Thorac Cardiovasc Surg. 2001;122:1125-1141.
72. De Bonis M, Lapenna E, La Canna G, et al. Mitral valve repair for functional mitral regurgitation in end-stage dilated cardiomyopathy: role of the "edge-to-edge" technique. Circulation. 2005;112(suppl 9):1402-1408.
73. Carpentier A, Chauvaud S, Fabiani JN, et al. Reconstructive surgery of mitral valve incompetence: ten-year appraisal. J Thorac Cardiovasc Surg. 1980;79: 338-348.
74. Cohn LH, Kowalker W, Bhatia S, et al. Comparative morbidity of mitral valve repair versus replacement for mitral regurgitation with and without coronary artery disease. Ann Thorac Surg. 1988;45:284-290.
75. Cohn LH, Rizzo RJ, Adams DH, et al. The effect of pathophysiology on the surgical treatment of ischemic mitral regurgitation: operative and late risks of repair versus replacement. Eur J Cardiothorac Surg. 1995;9:568-574.
76. Grossi EA, Goldberg JD, LaPietra A, et al. Ischemic mitralvalve reconstruction and replacement: comparison of long-term survival and complications. J Thorac Cardiovasc Surg. 2001;122:1107-1124.
77. Al-Radi OO, Austin PC, Tu JV, et al. Mitral repair versus replacement for ischemic mitral regurgitation. Ann Thorac Surg. 2005;79:1260-1267.
78. Kron IL, Green GR, Cope JT. Surgical relocation of the posterior papillary muscle in chronic ischemic mitral regurgitation. Ann Thorac Surg. 2002;74: 600-601.
79. Messas E, Guerrero JL, Handschumacher MD, et al. Chordal cutting: a new therapeutic approach for ischemic mitral regurgitation. Circulation. 2001; 104:1958-1963.
80. Spoor MT, Geltz A, Bolling SF. Flexible versus nonflexible mitral valve rings for congestive heart failure: differential durability of repair. Circulation. 2006;114:I67-I71.
81. McGee EC, Gillinov AM, Blackstone EH, et al. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2004;128:916-924.
82. Tahta SA, Oury JH, Maxwell JM, et al. Outcome after mitral valve repair for functional ischemic mitral regurgitation. J Heart Valve Dis. 2002;11:11-18.
83. von Oppell UO, Stemmet F, Brink J, et al. Ischemic mitral valve repair surgery. J Heart Valve Dis. 2000;9:64-74.
84. Hung J, Papakostas L, Tahta SA, et al. Mechanism of recurrent ischemic mitral regurgitation after annuloplasty: continued LV remodeling as a moving target. Circulation. 2004;110(suppl 2):85-90.
85. Breithardt OA, Sinha AM, Schwammenthal E, et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol. 2003;41:765-760.
86. Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchro-nization on morbidity and mortality in heart failure. N Engl J Med. 2005; 352:1539-1549.
87. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845-1853.
88. Brandt RR, Reiner C, Arnold R, et al. Contractile response and mitral regurgitation after temporary interruption of long-term cardiac resynchroni-zation therapy. Eur Heart J. 2006;27:187-192.
89. Grigioni F, Enriquez-Sarano M, Zehr K, et al. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 2001;103:1759-1764.
90. Haan CK, Cabral CI, Conetta DA, et al. Selecting patients with mitral regurgitation and left ventricular dysfunction for isolated mitral valve surgery. Ann Thorac Surg. 2004;78:820-825.
91. Calafiore AM, Mauro MD, Gallina S, et al. Surgical treatment of mitral valve regurgitation in dilated cardiomyopathy. Heart Surg Forum. 2004;7:21-25.
92. Nicolini F, Zoffoli G, Cagnoni G, et al. Mitral valve annuloplasty and myocardial revascularization in the treatment of ischemic dilated cardiomy-opathy. Heart Vessels. 2006;21:28-32.
93. Digiammarco G, Liberi R, Giancane M, et al. Recurrence of functional mitral regurgitation in patients with dilated cardiomyopathy undergoing mitral valve repair: how to predict it. Interact Cardiovasc Thorac Surg. 2007;6:340-344.